No membership fee required. No yearly fees. Only pay for what you want. Cancel anytime.

Apexion Health Wolverine peptide stack vial
LONGEVITYPEPTIDE STACK

MONTHLY SUPPLY · INJECTION

WOLVERINE: BPC-157 + TB-500

TREATMENT

Synergistic healing stack combining two potent regenerative peptides for accelerated recovery from soft tissue injuries, joint stress, and inflammatory damage.

SUPPORT

Wolverine combines BPC-157 and TB-500 — two peptides with complementary healing mechanisms. BPC-157 excels at angiogenic healing and gastrointestinal protection, while TB-500 supports cellular migration, proliferation, and tissue remodeling. Together, they create a powerful synergy for accelerating recovery from various types of tissue injury and stress.

Shop Now

Lab-Tested · Physician-Supervised · Discreet Delivery

Apexion Health — LONGEVITY

TWO PEPTIDES. ACCELERATED RECOVERY.

The Wolverine stack leverages the complementary strengths of two well-researched healing peptides. BPC-157 provides potent angiogenic and anti-inflammatory effects, particularly beneficial for tendon, ligament, and gastrointestinal healing. TB-500 (thymosin beta-4) excels at promoting cell migration and differentiation, which is essential for tissue remodeling and repair. Together, they address both the creation of a healing-friendly environment (BPC-157) and the active rebuilding process (TB-500) for comprehensive tissue recovery.

Clinical Benefits

WOLVERINE: BPC-157 + TB-500 SUPPORTS YOUR HEALTH AT THE CELLULAR LEVEL

  1. 01.

    COMBINES TWO SYNERGETIC HEALING PEPTIDES

  2. 02.

    TARGETS SOFT TISSUE, TENDON, AND JOINT HEALING

  3. 03.

    PROVIDES BOTH ANGIOGENIC AND CELLULAR REMODELING EFFECTS

  4. 04.

    ACCELERATES RECOVERY FROM INJURIES AND INFLAMMATORY STRESS

  5. 05.

    PHYSICIAN-SUPERVISED COMBINATION THERAPY

Shop Now

Clinical Evidence

How It Works in the Body

01 — Dose & Efficacy

Dual-Peptide Healing Synergy

Angiogenesis (BPC-157) New vessel formation to injury site65%
Cell Migration (TB-500) Actin-driven tissue remodeling60%
Inflammation Control Combined anti-inflammatory action55%

Seiwerth et al., Curr Pharm Des 2018; Goldstein et al., J Invest Dermatol 2012

02 — Hormone Panel

BPC-157 vs TB-500: Complementary Profiles

MarkerWithoutWith Treatment
BPC-157 — Angiogenesis
Impaired blood supply
VEGF upregulationEnhanced
BPC-157 — GI Protection
Mucosal vulnerability
NO-mediated protectionRestored
TB-500 — Cell Migration
Slow remodeling
Actin dynamics restoredAccelerated
TB-500 — Anti-fibrotic
Excess scar formation
Balanced tissue architectureOptimized

BPC-157 builds the scaffold, TB-500 directs the repair crew

Wolverine pairs BPC-157's angiogenic and GI-protective properties with TB-500's actin-regulating cell migration effects. BPC-157 ensures oxygen and nutrients reach the injury; TB-500 mobilizes and directs the cells that rebuild the tissue. Together they cover both the vascular and cellular phases of healing.

Seiwerth et al. 2018; Goldstein et al. 2012; Malinda et al., J Invest Dermatol 1999

03 — Protocol

Wolverine Recovery Protocol

AssessmentPre-treatment
  • ›Injury/tissue assessment
  • ›Baseline function & pain scores
  • ›Identify primary recovery goals
Intensive HealingWeeks 1–8
  • ›BPC-157 250–500 mcg + TB-500 2.5–5 mg SC weekly
  • ›Inject near injury site when possible
  • ›Weekly function & symptom tracking
ConsolidationWeek 8+
  • ›Reassess tissue status at 8 weeks
  • ›Continue or adjust dosing frequency
  • ›Taper as function returns to baseline

Dual-injection protocol — BPC-157 daily, TB-500 1–2× weekly

TB-500's longer half-life allows less frequent dosing (typically 1–2× weekly) while BPC-157 is dosed daily for sustained angiogenic support. TB-500 dosing timing may be coordinated around BPC-157 injections for convenience.

All protocols physician-supervised and adjusted per individual labs.